PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 10.995
AS - Asia 5.525
EU - Europa 5.182
SA - Sud America 938
AF - Africa 110
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 22.769
Nazione #
US - Stati Uniti d'America 10.772
SG - Singapore 2.136
CN - Cina 1.462
IT - Italia 1.084
HK - Hong Kong 916
RU - Federazione Russa 854
DE - Germania 822
BR - Brasile 774
SE - Svezia 572
IE - Irlanda 513
VN - Vietnam 394
UA - Ucraina 314
GB - Regno Unito 246
AT - Austria 214
FR - Francia 153
CA - Canada 142
IN - India 124
FI - Finlandia 107
KR - Corea 84
TR - Turchia 71
AR - Argentina 70
JP - Giappone 69
DK - Danimarca 63
NL - Olanda 62
BD - Bangladesh 61
ID - Indonesia 60
MX - Messico 51
ZA - Sudafrica 48
ES - Italia 43
IQ - Iraq 39
PL - Polonia 29
CO - Colombia 25
SA - Arabia Saudita 24
EC - Ecuador 18
EG - Egitto 16
PY - Paraguay 16
BE - Belgio 15
UZ - Uzbekistan 15
GR - Grecia 14
CH - Svizzera 12
LT - Lituania 12
PT - Portogallo 12
PE - Perù 11
VE - Venezuela 11
PK - Pakistan 10
DZ - Algeria 8
IR - Iran 8
MA - Marocco 8
AU - Australia 7
CZ - Repubblica Ceca 7
PA - Panama 7
CL - Cile 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
EU - Europa 5
KZ - Kazakistan 5
TN - Tunisia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
MY - Malesia 4
NO - Norvegia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
BG - Bulgaria 3
CR - Costa Rica 3
HU - Ungheria 3
LV - Lettonia 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
HR - Croazia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
TW - Taiwan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
Totale 22.752
Città #
Ann Arbor 2.328
Singapore 1.301
Ashburn 914
Hong Kong 912
Fairfield 670
Woodbridge 670
Chandler 562
Dallas 501
Dublin 496
Frankfurt am Main 482
Houston 481
Wilmington 471
Jacksonville 298
Seattle 297
New York 275
Beijing 262
Dearborn 261
Milan 246
Cambridge 222
Princeton 194
Vienna 193
Hefei 184
Santa Clara 183
Los Angeles 156
Nanjing 142
Ho Chi Minh City 122
The Dalles 105
Lawrence 92
Altamura 91
Seoul 79
São Paulo 78
Hanoi 76
Moscow 74
Chicago 72
Shanghai 68
Buffalo 65
San Diego 55
Dong Ket 48
Jakarta 48
Guangzhou 47
Lachine 43
Nanchang 43
Rome 38
Falls Church 37
London 37
Boardman 36
Tokyo 34
Munich 33
Lissone 32
Shenyang 32
Andover 31
Jinan 31
Nuremberg 30
Helsinki 29
Council Bluffs 28
Tianjin 28
Changsha 26
Pune 26
Brooklyn 25
Salt Lake City 25
Ottawa 24
Zhengzhou 24
Columbus 22
San Jose 22
Toronto 22
Montreal 21
Tampa 21
Hebei 20
Belo Horizonte 19
Haiphong 19
Ningbo 19
Warsaw 19
Hangzhou 18
Johannesburg 18
Atlanta 17
Denver 17
Rio de Janeiro 17
Turku 17
Kunming 16
Norwalk 16
Brussels 15
Fremont 15
Jiaxing 15
Monza 15
Baghdad 14
Chennai 14
Manchester 14
Orem 14
Phoenix 14
Stockholm 14
Tashkent 14
Brasília 13
Campinas 13
Dhaka 13
Düsseldorf 13
Huizen 13
Mexico City 13
Redmond 13
Boston 12
Edmonton 12
Totale 15.126
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 597
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 460
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 448
The putative role of MALDI-MSI in the study of Membranous Nephropathy 386
Microscopic Polyangiitis 360
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 349
MALDI imaging in Fabry nephropathy: a multicenter study 349
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 345
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 334
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 328
Kidney Involvement 321
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 317
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 310
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 309
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 304
Proteomics for the study of new biomarkers in Fabry disease: State of the art 284
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 271
Usefulness of waist circumference for the identification of childhood hypertension 264
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 254
Obesity-associated hypertension in childhood: A new epidemic problem 253
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 251
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 251
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 245
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 244
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 244
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 244
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 244
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 243
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 240
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 222
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 221
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 220
Role of fat distribution indicators in the identification of hypertension in children 217
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 215
Parapelvic cysts, a distinguishing feature of renal Fabry disease 212
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 212
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 210
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 209
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 209
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 209
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 207
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 207
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 206
Sympathetic activation in cardiovascular and renal disease 203
Renal afferents signaling diuretic activity in the cat 201
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 196
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 196
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 195
Protein-Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: Is There a Role for Adsorption Hemodiafiltration? 194
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 192
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 190
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 189
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 189
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 189
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 188
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 186
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 186
Anticoagulant-related nephropathy: a pathological note 184
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 182
ANCA-associated vasculitis in childhood: Recent advances 180
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 175
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 173
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 173
Tumour incidence in Fabry disease: A cross-sectional study 171
Hypertension in childhood: autonomic and metabolic patterns 170
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 170
La terapia enzimatica sostitutiva nella malattia di Fabry 169
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 168
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 167
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 166
Analysis of heart period and arterial pressure variability in childhood hypertension: Key role of baroreflex impairment 166
La diagnosi precoce di malattia 164
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 161
Redefining the pulvinar sign in fabry disease 161
[Clinical and histological findings in Fabry nephropathy] 158
Avacopan for the treatment of ANCA-associated vasculitis 158
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 158
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 155
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 154
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 154
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 154
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 154
Interpretation of GFR slope in untreated and treated adult Fabry patients 151
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 147
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 146
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 146
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 142
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 141
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 138
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 134
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 133
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 133
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 128
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 127
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 124
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 123
Cardiological follow-up in patients with Fabry disease 123
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 120
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 119
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 117
Totale 21.256
Categoria #
all - tutte 78.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.620 0 0 0 0 0 251 278 308 218 215 148 202
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20254.413 266 395 261 189 345 148 270 133 511 813 402 680
2025/20265.492 1.145 705 1.059 976 1.185 422 0 0 0 0 0 0
Totale 23.359